600812 华北制药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资1,277,4872.44%1,247,0861,187,0391,202,161900,516
投资性房地产0--0000
固定资产6,144,217-3.43%6,362,2346,298,7106,446,8316,786,065
在建工程321,90024.00%259,601381,137162,347154,672
无形资产3,032,2180.26%3,024,4972,755,9971,974,8211,650,332
商誉0--003,3373,337
其他非流动资产2,374,5710.31%2,367,1902,589,2953,149,6122,743,198
13,150,393-0.83%13,260,60713,212,17812,939,10912,238,119

流动资产
货币资金1,179,655-23.47%1,541,4141,660,279988,2761,682,737
应收账款2,549,7375.74%2,411,3692,049,3771,930,9032,231,066
存货2,472,0752.54%2,410,8522,510,5352,607,7842,523,301
其他流动资产1,776,7640.51%1,767,6612,039,0902,490,6282,545,794
7,978,230-1.88%8,131,2968,259,2808,017,5918,982,899

流动负债
短期借款5,736,842-8.09%6,242,1247,094,9955,467,7105,276,064
应付票据497,0024.28%476,611451,197581,040829,406
应付帐款2,030,0812.82%1,974,4091,843,8801,908,8551,953,227
其他流动负债2,235,906-39.67%3,706,1201,571,4572,310,9604,350,522
10,499,831-15.32%12,399,26410,961,53010,268,56512,409,219
流动资产净值(2,521,600)-40.92%(4,267,968)(2,702,250)(2,250,974)(3,426,320)
资产总额减流动负债10,628,79318.19%8,992,63910,509,92810,688,1358,811,799

非流动负债
长期借款3,048,858121.47%1,376,6753,458,9214,080,8582,129,070
应付债券500,0000.00%500,000000
其他非流动负债211,973-8.22%230,967376,395336,866454,353
3,760,83178.44%2,107,6423,835,3154,417,7252,583,423

总权益
    实收股本1,715,7300.00%1,715,7301,715,7301,715,7301,715,730
    储备项目3,802,6560.09%3,799,1013,673,6733,599,5733,584,395
股东权益5,518,3870.06%5,514,8315,389,4035,315,3045,300,125
非控股权益1,349,576-1.50%1,370,1661,285,210955,107928,251